This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Cartel damages lawsuits mean EU antitrust watchdogs can’t rely on leniency, Mundt warns

By Michael Acton ( May 14, 2019, 17:57 GMT | Insight) -- EU antitrust watchdogs must ensure their cartel leniency programs “remain attractive,” and should focus on other means of detecting cartels as the risk of damages lawsuits is deterring companies from coming forward, International Competition Network Chair Andreas Mundt said. While leniency programs — where businesses come forward and confess to cartels in return for reduced fines — remain “a very important tool” for EU antitrust enforcers, the growing risk they will face huge private lawsuits is making the option less attractive, Mundt said.EU antitrust watchdogs must ensure their cartel leniency programs “remain attractive,” and should focus on other means of detecting cartels as the risk of damages lawsuits is deterring companies from coming forward, International Competition Network Chair Andreas Mundt said today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections